Eagle Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four
Eagle Pharmaceuticals, Inc. had Lessee, Operating Lease, Liability, to be Paid, Year Four of $413.00 thousand as of 2021-12-31, per its 10-K filed 2022-03-08.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour · last filed 2022-03-08
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Four $413.00K.
- 2021-09-30: Lessee, Operating Lease, Liability, to be Paid, Year Four $413.00K.
- 2021-06-30: Lessee, Operating Lease, Liability, to be Paid, Year Four $413.00K.
- 2021-03-31: Lessee, Operating Lease, Liability, to be Paid, Year Four $413.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Four |
|---|---|
| 2021-12-31 | $413.00K 10-K · filed 2022-03-08 |
| 2021-09-30 | $413.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $413.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $413.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $1.04M 10-K · filed 2021-03-05 |
| 2020-09-30 | $820.00K 10-Q · filed 2020-11-02 |
| 2020-06-30 | $820.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $1.29M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $1.29M 10-Q · filed 2020-11-02 |
| 2019-09-30 | $1.38M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $583.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $583.00K 10-Q · filed 2019-05-07 |